GammaTiles Help Prevent Recurrence of Malignant Brain Tumors After Surgery

GammaTiles Help Prevent Recurrence of Malignant Brain Tumors After Surgery

GammaTiles

GT Medical Technologies, a company based in Tempe, Arizona, won FDA clearance for its GammaTiles to be used to prevent malignant brain tumors in newly diagnosed patients. The devices, about the size of a postage stamp, contain Cesium-131, a radioactive isotope with a half life of about ten days.

The collagen material within which the radioactive seeds are placed is resorbable by the body and doesn’t require a separate extraction procedure. This surgically targeted radiation therapy procedure was recently made available in a few hospitals for patients with recurrent brain tumors, but the new indication makes the devices, a rare new treatment, available for new cases.

Sourced through Scoop.it from: www.medgadget.com

Who We Are

Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.

Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.

Learn MoreOmnica Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *